Founded in Nanning National Hi-tech Industry Development Zone, Guangxi, China in August 2003, Wincon TheraCells Biotechnologies Co.,Ltd. (“Wincon”) is a world-famous research-driven biomedical service company specializing in research and development of disease models and related technologies in non-human primate (NHP).
Through years of development, Wincon has developed a variety of special disease models, which has contributed to our leading position in this field, such as the research on Alzheimer’s disease model . In the meanwhile, Wincon has been building to be a distinctive primate experiment and open technical platform by relying on the clinical experience and preclinical research capability of our core and professional team, as well as taking advantage of the abundant local resource of primate experimental animals, which provides professional and customized services and solutions for pharmaceutical companies, biotech companies, universities and scientific research institutions, including services for research and development of drugs and other health products (drugs, biologics, diagnostic products, medical devices and scientific Instruments) as well as biomedical research services.
As the first primate facility fully accredited by AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) in China, Wincon always strictly comply with the regulation for humane care and use of laboratory animals and guarantee the animal welfare and the quality of animal experiment.
Based on the customers’ actual demands and research purposes, Wincon devotes to help the customers design the study through the integration of technology and animal resources, and provide services researchers with high quality, efficient and cost-effective services through contract research services, cooperative studies, collaborative product developments, technology incubations, transfers of technology and primary products and the leases of facilities and other complementary cooperation, etc.
To meet the customers’ unmet needs and high quality requirements of product development and biomedical research, Wincon always insist on dedicating to constantly improving the research level and the capabilities of new technology development and platform services, The goal of Wincon is to extend the value chain on the basis of keeping the core advantages, and gradually develop into an international top-class biotech company through sustained innovation and cooperation.